AngioDynamics (NASDAQ:ANGO) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.12) by 14.53 percent. This is a 9.09 percent increase over losses of $(0.11) per share from the same period last year. The company reported quarterly sales of $75.711 million which beat the analyst consensus estimate of $72.725 million by 4.11 percent. This is a 12.18 percent increase over sales of $67.491 million the same period last year.